Alpha 2.0
Login Register
» Articles » PMID: 18042926

Trend Toward Noninferiority Trials May Mean More Difficult Interpretation of Trial Results

Overview
Journal J Natl Cancer Inst
Publisher Oxford University Press
Specialty Oncology
Date 2007 Nov 29
PMID 18042926
Citations 4
Authors
Rabiya S Tuma
Affiliations
Soon will be listed here.
Citing Articles

Noninferior Antibiotics: When Is "Not Bad" "Good Enough"?.

DiNubile M Open Forum Infect Dis. 2016; 3(3):ofw110.

PMID: 27382597 PMC: 4929489. DOI: 10.1093/ofid/ofw110.

A clinician's guide to the assessment and interpretation of noninferiority trials for novel therapies.

Oczkowski S Open Med. 2014; 8(2):e67-72.

PMID: 25009686 PMC: 4085087.

Creative trial design in RA: optimizing patient outcomes.

Buch M, Pavitt S, Parmar M, Emery P Nat Rev Rheumatol. 2013; 9(3):183-94.

PMID: 23381561 DOI: 10.1038/nrrheum.2013.5.

Rationale for and methods of superiority, noninferiority, or equivalence designs in orthopaedic, controlled trials.

Vavken P Clin Orthop Relat Res. 2011; 469(9):2645-53.

PMID: 21246313 PMC: 3148367. DOI: 10.1007/s11999-011-1773-6.